Naim Alkhouri, MD
Enriched profileChief Academic Officer, Summit Clinical Research; Director, Steatotic Liver Program, Clinical Research Institute of Ohio (CRIOH) · Clinical Research Institute of Ohio (CRIOH)
Naim Alkhouri is Chief Academic Officer, Summit Clinical Research; Director, Steatotic Liver Program, Clinical Research Institute of Ohio (CRIOH) at Clinical Research Institute of Ohio (CRIOH). OpenAlex indexes 680 publications with 21,714 citations (h-index 75); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Naim Alkhouri, MD, is Chief Academic Officer, Summit Clinical Research at Clinical Research Institute of Ohio (CRIOH), Westlake, OH. The public record shows 680 publications with 21,714 citations (h-index 75), centered on Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Liver Diseases and Immunity. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 52 companies.
- Most recent indexed publication: 2026 · Alimentary pharmacology & therapeutics
- Top research focus: Liver Disease Diagnosis and Treatment
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 52 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 220.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Phase 2a Study of HPG1860 in Subjects With NASH
Sponsor: Hepagene (Shanghai) Co., Ltd.
Industry payments
Updated 27 Aug 2026
52 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year2025160 payments$256,367openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year202543 payments$99,161openpaymentsdata.cms.gov ↗
- Ipsen Biopharmaceuticals, IncProgram year202524 payments$58,238openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
51%Bile Acid15.3%Ursodiol100%Part D≥43 patientsRifamycin Antibacterial10.6%Xifaxan100%Part D≥26 patientsCardiovascular
32.3%Aldosterone antagonist (MRA)12.1%Spironolactone100%Part D≥48 patientsLoop diuretic10.8%Furosemide100%Part D≥39 patientsAnti-infectives
11.3%Nucleoside and nucleotide reverse transcriptase inhibitors8.5%Vemlidy76%Tenofovir Disoproxil Fumarate24%Part D<11 patientsHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor2.9%Epclusa100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 27 Aug 2026
8 congress contributions (2016–2025) across ADA, ASCO per OpenAlex. The most recent:
- 528-P: Awareness of MASLD among People with Diabetes in Four Major U.S. Cities
ADA Scientific Sessions
ADA2025Co-authorPoster - 1456-P: Identifying Diabetic and Prediabetic Patients Who Require Pharmacotherapy for Nonalcoholic Steatohepatitis Using the FAST Score
ADA Scientific Sessions
ADA2020Co-authorPoster - 184-OR: Liver Fibrosis Scores Do Not Predict Response to Therapy in T2DM
ADA Scientific Sessions
ADA2020Co-authorOral
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Review Article: An Update on Non-Invasive Tests for Steatotic Liver Disease - Insights From the ESSENCE Phase 3 Trial and Longitudinal Studies.
Alimentary pharmacology & therapeutics
Review2026 - Effects of Resmetirom on Metabolic-Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon-Like Peptide-1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO-NASH Trial.
Alimentary pharmacology & therapeutics
Clinical Trial2025 - Resmetirom-eligible population among US adults: An estimation analysis based on NHANES 2017-March 2020.
Hepatology communications
Article2025 - Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) in 4 major cities in the United States.
Hepatology communications
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/alkhouri-naim-20552049
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/naim-alkhouri-md-faasld-3b13074b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Naim-Alkhouri
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/reel/C6NFLJtv4CX
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
my.clevelandclinic.org/staff/109703-naim-alkhouri
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗ - Apple Podcasts
podcasts.apple.com/de/podcast/naim-alkhouri-md-faasld-dabom-dont-wait-and-look/id718222632
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗
- Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →my.clevelandclinic.org ↗ - Board Certified
Obesity Medicine (DABOM, Diplomate American Board of Obesity Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohioresearch.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohioresearch.com ↗
Editorial & leadership roles
journal and society appointments- Chief Academic Officer
Summit Clinical Research, San Antonio, TX
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗ - Director
Steatotic Liver Program / Director of Research, Clinical Research Institute of Ohio (CRIOH)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohioresearch.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohioresearch.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →azliver.com ↗
Secondary affiliations
appointments beyond the home institution- Former Chief Medical Officer
Chief of Transplant Hepatology, and Director of the Steatotic Liver Program, Arizona Liver Health, Phoenix, AZ
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗ - Staff physician
Cleveland Clinic Community Hospital / Avon Hospital, Regional Operations (secondary/legacy listing)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →my.clevelandclinic.org ↗ - Former Director
Metabolic Health Center, Texas Liver Institute; former Associate Professor of Medicine and Pediatrics, University of Texas Health Science Center at San Antonio
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajmc.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona